Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Lower hair zinc and copper levels found in Turkish males with hair loss; higher BMI linked to less hair zinc.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The new rodent model successfully mimics non-lean human PCOS symptoms.

The Protein-Sparing Modified Fast is effective for rapid weight loss and maintaining it, but requires medical supervision and can have side effects.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Men prefer less invasive cosmetic procedures and need different treatment approaches than women.

Women with skin conditions who have body image concerns often experience mental health issues and a lower quality of life.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Men with testicular cancer were less likely to experience baldness and severe acne.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Certain MC4R gene variants are linked to higher BMI in obese women with PCOS but do not cause PCOS.

New treatments for PCOS focus on managing symptoms and improving fertility.